116 related articles for article (PubMed ID: 2256356)
21. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
22. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
[TBL] [Abstract][Full Text] [Related]
23. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
24. [Papillary carcinoma of the thyroid gland (author's transl)].
Krisch K; Depisch D; Jakesz R; Keminger K; Kokoschka R
Wien Klin Wochenschr; 1980 Feb; 92(4):113-8. PubMed ID: 7395226
[TBL] [Abstract][Full Text] [Related]
25. Optimizing treatment for children and adolescents with papillary thyroid carcinoma in post-Chernobyl exposed region: The roles of lymph node dissections in the central and lateral neck compartments.
Fridman M; Krasko O; Lam AK
Eur J Surg Oncol; 2018 Jun; 44(6):733-743. PubMed ID: 29397264
[TBL] [Abstract][Full Text] [Related]
26. A 29-year retrospective review of papillary thyroid cancer in one institution.
Lin JD; Chen ST; Hsueh C; Chao TC
Thyroid; 2007 Jun; 17(6):535-41. PubMed ID: 17614774
[TBL] [Abstract][Full Text] [Related]
27. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
28. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
29. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid carcinoma: prognostic index for survival including the histological variety.
Sebastian SO; Gonzalez JM; Paricio PP; Perez JS; Flores DP; Madrona AP; Romero PR; Tebar FJ
Arch Surg; 2000 Mar; 135(3):272-7. PubMed ID: 10722027
[TBL] [Abstract][Full Text] [Related]
31. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system.
Salvesen H; Njølstad PR; Akslen LA; Albrektsen G; Søreide O; Varhaug JE
Eur J Surg; 1992; 158(11-12):583-9. PubMed ID: 1363062
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of surgical treatment of papillary thyroid carcinoma].
Zhang ZM; Li ZJ; Tang PZ; Xu ZG; An CM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):779-82. PubMed ID: 22335912
[TBL] [Abstract][Full Text] [Related]
33. [Management of the neck for patients with thyroid papillary carcinoma].
Yin Y; Xu Z; Tang P
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):321-3. PubMed ID: 11778561
[TBL] [Abstract][Full Text] [Related]
34. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.
Yin X; Liu C; Guo Y; Li X; Shen N; Zhao X; Yu P; Wang S; Liu Z
World J Surg Oncol; 2017 Jul; 15(1):133. PubMed ID: 28716127
[TBL] [Abstract][Full Text] [Related]
35. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
[TBL] [Abstract][Full Text] [Related]
36. [Prognostically relevant factors in follicular thyroid cancer].
Böttger T; Klupp J; Sorger K; Junginger T
Langenbecks Arch Chir; 1990; 375(5):266-71. PubMed ID: 2259260
[TBL] [Abstract][Full Text] [Related]
37. Soft tissue invasion of papillary thyroid carcinoma.
Lin JD; Hsueh C; Chao TC
Clin Exp Metastasis; 2016 Aug; 33(6):601-8. PubMed ID: 27154220
[TBL] [Abstract][Full Text] [Related]
38. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G
J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
[TBL] [Abstract][Full Text] [Related]
39. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract][Full Text] [Related]
40. [Surgical management of upper mediastinal lymph nodes metastases from thyroid carcinoma].
Li ZJ; Miao XX; Tang PZ; Xu ZG; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):145-7. PubMed ID: 16750024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
